What predicts adherence to follow-up recommendations for abnormal Pap tests among older women?

Gynecologic Oncology

Volumn 105, Issue 1, 2007, Pages 74-80

  Coker, Ann L ^a   Eggleston, Katherine S ^a   Meyer, Tamra E ^a   Luchok, Kathryn ^b   Das, Irene Prabhu ^c  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF SOUTH CAROLINA   (United States)

^c SOUTH CAROLINA DEPARTMENT OF HEALTH AND ENVIRONMENTAL CONTROL   (United States)

Author keywords

Cervical neoplasms; Colposcopy; Patient compliance; Screening; Women

Indexed keywords

ADULT; AFRICAN AMERICAN; AGE DISTRIBUTION; ARTICLE; CANCER SCREENING; CONTROLLED STUDY; DISEASE SEVERITY; EDUCATION; FEMALE; FOLLOW UP; HEALTH INSURANCE; HEALTH STATUS; HIGH RISK POPULATION; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PATIENT COMPLIANCE; PATIENT REFERRAL; PRIORITY JOURNAL; RACE DIFFERENCE; RISK ASSESSMENT; SMOKING; UTERINE CERVIX TUMOR;

AGE FACTORS; CERVIX UTERI; COLPOSCOPY; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERVIEWS; MIDDLE AGED; PATIENT COMPLIANCE; PROPORTIONAL HAZARDS MODELS; SOCIOECONOMIC FACTORS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 33947312673     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2006.10.046     Document Type: Article

References (36)

1. Ries LAG, Eisner MP, Kosary CL. Hankey B.F., Miser B.A., Clegg L., et al. SEER Cancer Statistics Review, 1975-2002, In. Bethesda, MD, http://seer.cancer.gov/csr/1975_2002/, based on November 2004 SEER data submission, posted to the SEER web site 2005: National Cancer Institute; 2005.
2. Cancer Statistics by State, 1993-1997. American Cancer Society (2005)
3. Koss L.G. Cervical screening: what is the point?. Lancet 346 8969 (1995) 245-247
4. Breast and cervical cancer screening among underserved women: National Cancer Institute Cancer Screening Consortium for Underserved Women; 1995.
5. Cancer Facts and Figures. Atlanta, GA: American Cancer Society; 2006.
6. Rajaram S.S. Non-adherence to follow-up treatment of an abnormal Pap smear: a case study. Cancer Nurs. 21 (1998) 342-348
7. Engelstad L.P., Stewart S.L., Nguyen B.H., Bedeian K.L., Rubin M.M., Pasick R.J., et al. Abnormal Pap smear follow-up in a high-risk population. Cancer Epidemiol., Biomarkers Prev. 10 (2001) 1015-1020
8. Hartz L.E., and Fenaughty A.M. Management choice and adherence to follow-up after colposcopy in women with cervical intraepithelial neoplasia 1. Obstet. Gynecol. 98 (2001) 674-679
9. Jones B.A., and Novis D.A. Follow-up of abnormal gynecologic cytology. Arch. Pathol. Lab. Med. 124 (2000) 665-671
10. Marcus A.C., Crane L.A., Kaplan C.P., Reading A.E., Savage E., Gunning J., et al. Improving adherence to screening follow-up among women with abnormal Pap smears: results from a large clinic-based trial of three intervention strategies. Med. Care 30 3 (1992) 216-230
11. Marcus A.C., Kaplan C.P., Crane L.A., Berek J.S., Bernstein G., Gunning J.E., et al. Reducing loss-to-follow-up among women with abnormal Pap smears. Results from a randomized trial testing an intensive follow-up protocol and economic incentives. Med. Care 36 3 (1998) 397-410
12. McKee M.D., Lurio J., Marantz P., Burton W., and Mulvihill M. Barriers to follow-up of abnormal Papanicolaou smears in an urban community health center. Arch. Fam. Med. 8 2 (1999) 129-134
13. Peterson N.B., Han J., and Freund K.M. Inadequate follow-up for abnormal Pap smears in an urban population. J. Natl. Med. Assoc. 95 (2003) 825-832
14. Engelstad L.P., Stewart S.L., Ostero-Sabogal R., Leung M.S., Davis P.I., and Pasick R.J. The effectiveness of a community outreach intervention to improve follow-up among underserved women at highest risk for cervical cancer. Prev. Med. 41 (2005) 741-748
15. Cardin V.A., Grimes R.M., Jiang Z.D., Pomeroy N., Harrell L., and Cano P. Low-income minority women at risk for cervical cancer: a process to improve adherence to follow-up recommendations. Public Health Rep. 116 (2001) 608-616
16. Paskett E.D., Phillips K.C., and Miller M.E. Improving compliance among women with abnormal Papanicolaou smears. Obstet. Gynecol. 86 3 (1995) 353-359
17. Benard V.B., Herschel L.W., Eheman C.R., Anderson C., and Helsel W. Adherence to guidelines for follow-up of low-grade cytologic abnormalities among medically underserved women. Obstet. Gynecol. 105 (2005) 1323-1328
18. Carey P., and Gjerdingen D.K. Follow-up of abnormal Papanicolaou smears among women of different races. J. Fam. Pract. 37 6 (1993) 583-587
19. Fox P., Amsberger P., and Zhang X. An examination of differential follow-up rates in cervical cancer screening. J. Commun. Health 22 3 (1997) 199-209
20. Eger R.R., and Peipert J.F. Risk factors for noncompliance in a colposcopy clinic. J. Reprod. Med. 41 9 (1996) 671-674
21. McKee M.D., Schechter C., Burton W., and Mulvihill M. Predictors of follow-up of atypical and ASCUS Pap test results in a high risk population. J. Fam. Pract. 50 (2001) 609-613
22. Melnikow J., Chan B.K., and Stewart G.K. Do follow-up recommendations for abnormal Papanicolaou smears influence patient adherence?. Arch. Fam. Med. 8 6 (1999) 510-514
23. Nelson K., Geiger A.M., and Mangione C.M. Effect of health beliefs on delays in care for abnormal cervical cytology in a multiethnic population. J. Gen. Int. Med. 17 (2002) 709-716
24. Ell K., Vourlekis B., Muderspach L., Nissley J., Padgett D., Pineda D., et al. Abnormal cervical screen follow-up among low-income Latinas: Project SAFe. J. Women's Health Gend.-based Med. 11 (2002) 639-651
25. Lerman C., Hanjani P., Caputo C., Miller S., Delmoor E., Nolte S., et al. Telephone counseling improves adherence to colposcopy among lower-income minority women. J. Clin. Oncol. 10 2 (1992) 330-333
26. Miller S.M., Siejak K.K., Schroeder C.M., Lerman C., Hernandez E., and Helm C.W. Enhancing adherence following abnormal Pap smears among low-income minority women: a preventive telephone counseling strategy. J. Natl. Cancer Inst. 89 (1997) 703-708
27. Paskett E.D., White E., Carter W.B., and Chu J. Improving follow-up after an abnormal Pap smear: a randomized controlled trial. Prev. Med. 19 6 (1990) 630-641
28. Takacs P., Chakhtoura N., and DeSantis T. Video colposcopy improves adherence to follow-up compared to regular colposcopy: a randomized trial. Arch. Gynecol. Obstet. 270 (2004) 182-184
29. Lavin C., Goodman E., Perlman S., Kelly L.S., and Emans S.J. Follow-up of abnormal Papanicolaou smears in a hospital-based adolescent clinic. J. Pediatr. Adolesc. Gynecol. 10 3 (1997) 141-145
30. Kaplan C.P., Bastani R., Belin T.R., Marcus A., Nasseri K., and Hu M.-Y. Improving follow-up after an abnormal Pap smear: results from a quasi-experimental intervention study. J. Women's Health Gend.-based Med. 9 (2000) 779-790
31. Coker A.L., Bond S.M., and Pirisi L.A. Life stressors are an important reason for women discontinuing follow-up care for cervical neoplasia. Cancer Epidemiol., Biomark. Prev. 15 2 (2006) 321-325
32. Crane L.A. Social support and adherence behavior among women with abnormal Pap smears. J. Cancer Educ. 11 3 (1996) 164-173
33. Ell K., Vourlekis B., Nissly J., Padgett D., Pineda D., Sarabia O., et al. Integrating mental health screening and abnormal cancer screening follow-up: an intervention to reach low-income women. Community Ment. Health J. 38 (2002) 311-325
34. French D.P., Maissi E., and Marteau T.M. Psychological costs of inadequate cervical smear test results. Br. J. Cancer 91 (2004) 1887-1892
35. Breitkopf C.R., Catero J., Jaccard J., and Berenson A.B. Psychological and sociocultural perspectives on follow-up of abnormal Papanicolaou results. Obstet. Gynecol. 104 (2004) 1347-1354
36. Lovejoy N.C., Roche N., and McLean D. Life stress and risk of precancerous cervical lesions: a pretest directed by the life stress model. Oncol. Nurs. Forum 24 1 (1997) 63-70